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Abstract 22 
Equine influenza is a highly contagious respiratory disease considered the most important 23 
respiratory disease in equids. Although influenza A virus (IAV) has caused outbreaks in 24 
equids worldwide, surveillance on these species in Spain has not been conducted. A cross-25 
sectional study was carried out to determine the individual and herd prevalence of 26 
antibodies against H3N8 and H7N7 IAV in equids in Andalusia (southern Spain). 27 
Antibody against IAV was measured by the single radial haemolysis assay. A spatial scan 28 
statistical analysis was carried out using a Bernoulli model. Risk factors associated with 29 
IAV infection were assessed by multivariate analysis. Antibodies to H3N8 IAV were 30 
detected in 241 out of 464 unvaccinated equids (51.9%; 95% CI: 47.4–56.5). 31 
Seropositivity against the H7N7 subtype IAV was not found in any of the analysed 32 
animals. Significantly higher seropositivity was found in geriatric (OR= 6.1, P = 0.008, 33 
95% CI= 1.6 – 23.1) and adult (OR= 4.8, P < 0.001, 95% CI= 2.5 – 9.0) equids compared 34 
to young. Specific antibodies against A/equine/Shropshire/2010 (H3N8) or 35 
A/equine/Newmarket/5/2003 (H3N8) only were confirmed in 11 and 45 of the animals, 36 
respectively. The spatial analysis showed a statistically significant cluster centred in the 37 
west part of Andalusia. The results confirmed widespread H3N8 subtype IAV exposure 38 
in equine species in Andalusia. Conversely, the absence of seropositivity against H7N7 39 
IAV obtained in the present study suggests that this subtype has not circulated in southern 40 
Spain in recent years. Because of the animal health and economic consequences of IAV 41 
in equids, further surveillance and molecular studies are required to monitor and 42 
characterize the most prevalent IAV circulating in these species in Spain. 43 
  44 
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Introduction 46 
Influenza A virus (IAV) is an enveloped single-stranded negative-sense RNA virus 47 
belonging to the Influenzavirus A genus (family Orthomyxoviridae). Influenza viruses are 48 
classified according to their two major surface glycoproteins: haemagglutinin (H1–H18) 49 
and neuraminidase (N1–11) (Tong et al. 2013). Although highly pathogenic avian 50 
influenza virus (H5N1) has been isolated from donkeys (Abdel-Moneim et al. 2010), only 51 
viruses of the H7N7 and H3N8 subtypes have been shown to circulate endemically among 52 
equine species. The H7N7 subtype, which was the first IAV isolated in horses in 1956 53 
(Sovinova et al. 1958), is considered extinct as this virus has not been detected from 54 
equids for over three decades (Webster, 1993). The H3N8 subtype was initially isolated 55 
in 1963 in Florida (Waddell et al. 1963) and subsequently spread globally. H3N8 IAV 56 
diverged into European and American lineages in the late 1980s (Daly et al. 1996). The 57 
American lineage was further divided into the Kentucky, South American, and Florida 58 
sub-lineages, with a more recent divergence between Florida clade 1 and clade 2 (OIE 59 
2009). Although viruses from both clades have caused outbreaks in equine species 60 
worldwide (OIE-WAHIS), Florida clade 1 have predominated in the USA but have been 61 
the cause of outbreaks in Africa, South America, Asia and Europe. Florida clade 2 strains 62 
are endemic in Europe and have also been implicated in outbreaks in Asia (Elton and 63 
Bryant, 2011).  64 
Equine influenza (EI) is a highly contagious and widespread infectious disease of horses 65 
and other equine species (OIE 2016). This disease is considered the most important 66 
respiratory disease in equids, as outbreaks rapidly spread through susceptible populations. 67 
Transmission occurs by direct contact, or indirectly through fomites and in aerosols. IAV 68 
infection in equids is a typically self-limiting respiratory disease characterized by fever, 69 
lethargy, coughing, dyspnoea and nasal discharge, particularly in naïve or unvaccinated 70 
4 
 
individuals (Firestone et al. 2011). Even though the mortality rate associated with IAV 71 
infection is low in horses, infected animals are prone to secondary bacterial infections 72 
that can lead to pneumonia and death (Back et al. 2011). Equine influenza causes severe 73 
economic losses for the horse industry by causing disruption of equestrian events, 74 
restrictions of movements and preventive and control measures (Cullinane et al. 2010). 75 
Although the H3N8 IAV is endemic in equids in Europe, epidemiological information on 76 
this subtype is still very limited in some regions. In Spain, EI outbreaks have not been 77 
reported and survey studies on IAV in equids have not been carried out. The aim of the 78 
present study was to determine the seroprevalence, risk factors and spatial distribution of 79 
IAV in equids in Andalusia (southern Spain). 80 
Material and Methods 81 
Study design 82 
A cross-sectional study was carried out to determine the individual and herd prevalence 83 
of antibodies against IAV in equids in Andalusia (36º N–38º 60´ N, 1º 75´W–7º 25´ W). 84 
Andalusia is the region with the largest number of equids in Spain with a total of 223 696 85 
equids recorded during a census conducted in 2015, including 189 790 horses, 19 926 86 
mules and 13 980 donkeys (CAP 2015). Initially, a total of 441 equine herds were 87 
surveyed by official veterinarians as part of a regional surveillance health programme 88 
carried out in Andalusia between 2011 and 2015. The sampling was stratified by 89 
provinces according to the proportion of horses in each province. The herds in each 90 
province were selected by simple random sampling from the official records of herds 91 
obtained from the Regional Government of Andalusia (CAP 2015). Based on the 92 
epidemiological questionnaire, 270 herds, in which vaccination programmes against IAV 93 
have been previously implemented, were excluded for this study. Finally, blood samples 94 
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from 234 unvaccinated horses were collected in the remaining 171 herds. Based on the 95 
size of the selected herds (ranging from 1 to 260; median= 7), an estimated within-herd 96 
prevalence of 50% and a confidence level of 95% (95% CI), between one and five horses 97 
were randomly sampled to detect seropositivity within each herd. Sampled horses were 98 
selected using systematic sampling. Additionally, blood was collected from 169 donkeys 99 
(from 41 herds) and 61 mules (from 39 herds) using convenience sampling. The 100 
geographical distribution of the analysed equine herds is represented in Figure 1. None 101 
of the sampled equids showed clinical signs compatible with equine influenza at the time 102 
of sample collection.  103 
An epidemiological questionnaire was carried out during the sampling through an on-104 
farm interview with the owners, in order to obtain data related to the herd and animals. 105 
The explanatory variables collected from the questionnaire were grouped as (a) individual 106 
data: age range (young: <5 years, adult: 5–14 years or geriatric: >14 years), gender (male 107 
or female), breed (purebred or crossbred), vaccination history (type of vaccine used and 108 
date of vaccination); (b) herd data: province, municipality, herd size (small: 1–5, medium: 109 
6–12 or big >21 animals), activity (farming, leisure or work), type of housing (outdoors 110 
(kept outdoors during the day), indoors (kept in shelter during the day) or mixed (free 111 
access to both types of housing)), direct contact with other horses, transport of horses 112 
within the last 6 months (< 6 months or > 6 months), presence of other equine species, 113 
presence of other animal species (birds, cats, dogs and pigs); (c) biosecurity measures: 114 
cleaning and disinfection at least one time per week. 115 
Sample collection and serological analyses 116 
Blood samples were collected by jugular venipuncture using sterile collection system 117 
tubes without anticoagulant (Vacutainer®, Becton-Dickinson, USA) and transported to 118 
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the laboratory under refrigeration within 24 h of sampling. Samples were centrifuged at 119 
400 g for 15 min, and sera separated and stored at -20ºC until analysis. 120 
Antibody levels against IAV were measured using the single radial haemolysis (SRH) 121 
assay performed as described in the OIE Terrestrial Manual (OIE 2016). Samples were 122 
tested in parallel using A/equine/Shropshire/2010 (H3N8) (Florida clade 1), 123 
A/equine/Newmarket/5/2003 (H3N8) (Florida clade 2) and A/equine/Prague/1956 124 
(H7N7) strains as antigens. Serum from a hyper-immunized experimental pony (Scott et 125 
al. 2012) and the relevant European Pharmacopoeia reference antiserum (Eq Influenza 126 
Subtype 1 Strain A/equine/Newmarket/1977 (H3N8) Horse Antiserum) for the 127 
A/equine/Prague/1956 (H7N7) strain were included as positive controls on each plate as 128 
appropriate. Serum samples with a clear zone of haemolysis were considered to be 129 
positive. 130 
Spatio-temporal cluster analysis 131 
A spatial scan statistical analysis was carried out at municipality level using a Bernoulli 132 
model to detect significant clusters of IAV presence in equine herds (Kulldorff et al. 133 
2006). The number of Monte Carlo simulations was set to 999 for the cluster scan statistic. 134 
Analyses were run using SaTScanTM v9.4.4. Clusters were considered to be significant 135 
at P < 0.05.  136 
Statistical analysis 137 
The prevalence of antibodies by SRH was estimated from the ratio of positives to the total 138 
number of samples, with the exact binomial confidence intervals of 95% (95% CI) 139 
(Thrushfield, 2007). Associations between serological results and explanatory variables 140 
were analysed using a Pearson’s chi-square test. All statistically significant variables 141 
(likelihood ratio and Wald test, P-value < 0.15) in the bivariate analysis were selected as 142 
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potential risk factors. Cramer’s V coefficient between pairs of variables was computed to 143 
prevent collinearity. Finally, a generalized estimating equation (GEE) was carried out to 144 
study the effect of the variables selected on the basis of bivariate analysis. The number of 145 
seropositive animals was assumed to follow a binomial distribution and both the “herd” 146 
and “province” were included as random effects. A forward introduction of variables was 147 
used, starting with the variable with the lowest P-value in bivariate analysis. At each step, 148 
the confounding effect of the included variable was assessed by computing the change in 149 
the odd ratios (OR). Confounding variables were those that, when added to the model, 150 
changed the OR by more than 30%. The model was re-run until all remaining variables 151 
presented statistically significant values (likelihood-ratio Wald’s test, P < 0.05) and a 152 
potential relationship with the response variable existed. The fit of the models was 153 
assessed using a goodness-of-fit test (Hanley et al. 2003). All the statistical analyses were 154 
performed using SPSS 20.0 (Statistical Package for Social Sciences, Inc., Chicago, IL, 155 
USA). 156 
 157 
Results 158 
Antibodies against H3N8 subtype IAV were detected in 241 of the 464 (51.9%; 95% CI: 159 
47.4–56.5) equids tested (Table 1). Seropositivity against H7N7 subtype IAV was not 160 
found in any of the 464 analysed sera. The distribution of individual and herd prevalence 161 
to A/equine/Shropshire/2010 (H3N8) and A/equine/Newmarket/5/2003 (H3N8) strains 162 
among species is shown in Table 1. The Bernoulli model identified one statistically 163 
significant cluster (radius: 30.1 Km; P < 0.027) centred in the west part of Andalusia 164 
(Figure 1).  165 
A total of nine explanatory variables were selected from the univariate analysis (Table 2). 166 
The “breed” was excluded from the multivariate analysis due to collinearity with the 167 
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variable presence of “shelter”, while “cleaning and disinfection” and “presence of other 168 
equids” had collinearity with “species”. The final GEE model showed that the main risk 169 
factor associated with IAV seroprevalence in equine species was age. Significantly higher 170 
seropositivity was found in geriatric (OR= 6.1, P = 0.008, 95% CI= 1.6 – 23.1) and adult 171 
(OR= 4.8, P < 0.001, 95% CI= 2.5 – 9.0) equids compared to young. Similar results were 172 
found when only horses were selected (geriatric: 87.5%, 42/48; OR= 32.8, P = 0.001, 173 
95%CI= 3.6 – 89.5; adults: 70.3%, 97/138; OR= 28.6, P = 0.001, 95%CI= 4.1 – 62.5 vs 174 
young animals: 25.0%, 12/48). 175 
Discussion 176 
The overall seroprevalence obtained in the present study (51.9%) indicates high H3N8 177 
subtype IAV exposure in equids in southern Spain. Reported rates of seropositive equids 178 
from different countries range from 26.4% in Israel to 67.6% in the UK (Aharonson-Raz 179 
et al. 2014; Barquero et al. 2007). However, the comparison of seroprevalence among 180 
studies should be interpreted carefully due to differences in methods used to measure 181 
antibodies, number of samples tested, equine species analysed and epidemiological 182 
context. 183 
The seroprevalence detected in mules (62.3%) and donkeys (30.8%) in the present study 184 
was higher than that found in these species in Turkey (mules: 12.8% and donkeys: 9.4%) 185 
(Ataseven and Daly, 2007) and in mules in Brazil (37.5%) (Gaiva e Silva et al. 2014). 186 
Most of the seropositive animals had positive results to both H3N8 IAV strains, which 187 
could be due to co-infections or, more probably, cross-reactivity between the two IAV 188 
Florida clades. However, specific seropositivity against A/equine/Newmarket/5/2003 189 
(H3N8) and A/equine/Shropshire/2010 (H3N8) strains suggest circulation of these two 190 
H3N8 IAV strains among the equine population tested. Nonetheless, the circulation of 191 
other strains detected in Europe should be considered. Seronegative results to H7N7 IAV 192 
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indicate absence of circulation of this subtype in southern Spain, which is consistent with 193 
reports that the virus no longer circulates in equids (Loroño-Pino et al. 2010; OIE 2017). 194 
Vaccination is considered the main tool to prevent IAV in equids (Elton and Bryant, 195 
2011). It was previously suggested that at least 70% of a given equine population needs 196 
to be fully vaccinated to prevent EI epidemics (Baker, 1986). However, mathematical 197 
modelling has suggested that this figure can be as low as 40% if the vaccine strain 198 
perfectly matches circulating viruses, but may need to be as high as 90% if there is 199 
substantial antigenic drift between the vaccine strain and circulating viruses (Park et al. 200 
2009). Based on the epidemiological questionnaire carried out to select the non-201 
vaccinated horse herds for this study, the 61.2% of the initially surveyed herds were 202 
vaccinated against IAV in the last 5 years (data not shown). Therefore, continuous 203 
monitoring of field IAV strains circulating in equids in Spain as well as vaccination 204 
programmes against these strains should be implemented in the studied area in order to 205 
verify the effectiveness of vaccines and avoid outbreaks due to lack of immunological 206 
protection.  207 
The herd seroprevalence levels obtained in this study indicated a widespread circulation 208 
of IAV in equids in southern Spain. However, the spatial distribution was not uniform 209 
across the municipalities. The spatial analysis showed a significantly higher IAV 210 
circulation in the western region of Andalusia (Huelva province). Interestingly, the cluster 211 
was located surrounding the Doñana National Park (DNP), the main wetland for water 212 
birds in Spain. The strategic location within important wild bird migratory flyways 213 
between Europe and Africa, the environmental conditions and the high density of horses, 214 
including unvaccinated feral and semi-wild horse populations (Retuerta and Marismeño 215 
breeds) in DNP, are possible factors implicated in the higher spread of IAVs in this area. 216 
The equine H3N8 IAV lineage is thought to have first emerged in horses in South 217 
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America as a result of direct transmission from the wild bird reservoir (Murcia et al. 2011) 218 
and a further ‘spill-over’ of the H3N8 subtype from wild birds to horses was detected in 219 
China in 1989 (Guo et al. 1992). Furthermore, antibodies against the avian IAV H3N8 220 
subtype have been previously detected in wild birds in Spain (Busquets et al. 2010; Pérez-221 
Ramírez et al. 2012). Although the equine-specific H3N8 IAV strains used in this study 222 
have circulated in horses for at least 40 years, some cross-reactivity with currently 223 
circulating avian H3N8 IAV strains may remain. Further studies could include testing of 224 
equine sera against currently-circulating strains of equine and avian H3N8 IAV.  Our 225 
results constitute an important step for understanding IAV spread in the studied area and 226 
will provide valuable information for the development of more cost-effective surveillance 227 
and control programmes in Spain.  228 
The multivariate analysis showed that the prevalence of IAV antibodies in equids was 229 
age-related, in accordance with several previous studies (Aharonson-Raz et al. 2014; 230 
Guildea et al. 2011; Laabassi et al. 2012). The higher seroprevalence in older animals 231 
reflects a cumulative likelihood for exposure to IAV and persistence of antibodies.  232 
In conclusion, this study confirms a widespread H3N8 subtype IAV exposure in equine 233 
species in Andalusia. Conversely, the absence of seropositivity against H7N7 IAV 234 
obtained in the present study suggests that this subtype has not circulated in southern 235 
Spain in recent years. The identification of spatial clusters can serve to inform risk-based, 236 
more cost-effective strategies towards better prevention and control of EI in Spain. 237 
Because of the animal health and economic consequences of IAV in equine populations, 238 
further surveillance and molecular studies are required to monitor and characterize the 239 
most prevalent IAV strains circulating in these species in Spain. In order to better prevent 240 
IAV outbreaks in naïve populations, specific measures, including quarantine of imported 241 
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equids and vaccination programmes should be implemented in the studied area, 242 
particularly surrounding the DNP, where the spatial cluster was detected. 243 
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Table 1. Individual and herd-level seroprevalence against influenza 371 
A/equine/Shropshire/2010 (H3N8) and A/equine/Newmarket/5/2003 (H3N8) in different 372 
equine species in southern Spain. 373 
Species  
Positive/ total 
(%; 95% Confidence interval) 
H3N8 subtype 
A/equine/Shropshire/
2010 (H3N8) strain* 
A/equine/Newmarket/
5/2003 (H3N8) strain 
Co-occurrence 
Horse 
Individual 
151/234 
(64.5; 58.4-70.7) 
139/227 
(61.2; 54.9-67.6) 
139/234 
(59.4; 53.1- 65.7) 
127/234 
(54.3; 47.9- 60.7) 
Herd 
123/171 
(71.9; 65.2-78.7) 
113/167 
(67.7; 60.6-74.7) 
112/171 
(65.5; 58.4-72.6) 
103/171 
(60.2; 52.9- 67.6) 
Donkey 
Individual 
52/169 
(30.8; 23.8-37.7) 
47/169 
(27.8; 21.1-34.6) 
37/169 
(21.9; 15.7-28.1) 
32/169 
(18.9; 13.0- 24.8) 
Herd 
13/41 
(31.7; 17.5-45.9) 
10/41 
(24.4; 11.3-37.5) 
12/41 
(29.3; 15.3-43.2) 
8/41 
(19.5; 7.4- 31.6) 
Mule 
Individual 
38/61 
(62.3; 50.1-74.5) 
37/61 
(60.7; 48.4-72.9) 
20/61 
(32.8; 21.0-44.6) 
19/61 
(31.15; 19.5- 42.8) 
Herd 
29/39 
(74.3; 60.7-88.1) 
28/39 
(71.8; 57.7-85.9) 
16/39 
(41.0; 25.6-56.5) 
15/39 
(38.5; 23.2%, 53.7) 
Total 
Individual 
241/464 
(51.9; 47.4–56.5) 
11/457 
(2.4; 1.0-3.8) 
45/464 
(9.7; 7.0-12.4) 
178/464 
(38.4; 33.9- 42.8) 
Herd
†
 
162/241 
(67.3; 61.3-73.2) 
150/237 
(63.3; 57.2-69.4) 
140/241 
(58.1; 51.9-64.3) 
127/241 
(52.7; 46.4-59.0) 
*Sera from seven horses from four herds could not be tested against 374 
A/equine/Shropshire/2010 (H3N8) due to low volume. †Two or more equine species 375 
coincided in ten herds. 376 
  377 
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Table 2. Distribution of variables identified as significant (P < 0.15 in the univariate 378 
analysis) and included in the multivariate analysis to determine the risk factors associated 379 
with AIV seroprevalence in equids in Andalusia (southern Spain). 380 
Variable Categories % Positive Number/overall* P value 
Equine species† Horses 
Mules 
Donkeys 
64.5 
62.3 
30.7 
151/234 
38/61 
52/169 
<0.0001 
Age† Geriatric 
Adults 
Young 
75.6 
58.6 
24.6 
65/86 
143/244 
33/134 
<0.0001 
Sex Male 
Female 
51.8 
51.9 
142/274 
98/189 
0.99 
Breed† Pure 
Crossbred 
46.4 
71.4 
170/366 
65/91 
<0.0001 
Herd size† Big 
Medium 
Small 
47.2 
42.2 
55.8 
50/106 
27/64 
164/294 
0.07 
Shelter† Indoors 
Outdoors 
Mixed 
69.2 
44.1 
53.4 
71/107 
120/272 
39/73 
<0.0001 
Cleaning and 
disinfection† 
Yes 
No 
52.4 
44.2 
118/225 
77/174 
0.06 
Activity Farming 
Leisure 
Work 
58.5 
49.7 
53.2 
38/65 
143/288 
58/109 
0.41 
Transport of equids† < 6 months 
> 6 months 
61.8 
47.2 
63/102 
93/197 
0.01 
Entrance of other 
equids 
< 1 months 
> 6 months 
1-6 months 
60.4 
58.8 
54.8 
64/106 
10/17 
17/31 
0.86 
Presence of other 
equids† 
Yes 
No 
56.7 
47.0 
89/157 
117/249 
0.03 
Presence of pigs Yes 
No 
49.8 
50.0 
23/46 
100/201 
0.98 
Presence of cats† Yes  
No 
56.7 
45.8 
101/178 
108/236 
0.02 
Presence of birds Yes  
No 
45.8 
51.8 
172/332 
38/83 
0.33 
Presence of dogs Yes  
No 
51.8 
44.6 
176/340 
33/74 
0.26 
19 
 
 *Missing values were omitted. †Variable included in the multivariate analysis. 381 
 382 
383 
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Figure legend 384 
Figure 1. Map of Andalusia (southern Spain) showing the gradient of seroprevalence at 385 
municipal level. The circle indicates the significant spatial cluster of herds with equids 386 
seropositive for AIV. 387 
